跳至主要内容
临床试验/CTRI/2015/04/005720
CTRI/2015/04/005720Other未知

An exploratory study to assess the effect of topical application of iodex balm on local surface temperature using infra red thermal imaging technique.

GlaxoSmithKline Pharmaceuticals Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Satisfactory completion of the consent procedure (subject understanding of the study,willingness to participate and receiving of the signed and dated copy of the consent form).
  • 2. age of the subject should be between 35 to 65.
  • 3. Subject understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 4. Good general and mental health of the subject with, in opinion of the investigator or medically qualified designee
  • a. No clinically significant and relevant abnormalities of medical history or physical examination
  • b. Absence of any condition that would impact on the subject safety or well being or affect the individual ability to understand and follow study procedures and requirements.
  • 5. Diagnosis subject is suffering from chronic osteoarthritis of knee joint as per ACR criteria for greater than three months.
  • 6. Females of childbearing potential who are, in the opinion of the investigator, practicing a reliable method of contraception.

排除标准

  • 1. Pregnancy: women who are known to be pregnant or who are intending to become pregnant over the duration of the study or who have a positive urine pregnancy test
  • 2.Breast-feeding: Women who are breast-feeding,
  • 3. Allergy/Intolerance: Known or suspected intolerance or hypersensitivity
  • to the study materials (or closely related compounds) or any of their stated ingredients,
  • 4.Subject has current or relevant previous history of serious, severe or unstable physical or psychiatric illness, or medical disorders, such as current or previous history of hepatic ( or renal diseases (impairment) or peptic ulcer as determined by medical history,
  • 5.Subject has psoriasis and/or active atopic dermatitis/eczema, and skin
  • infected lesions, burn or wound at th application site,
  • 6.Clinical Study/Experimental Medication:
  • a. Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit,
  • b. Previous participation in this study.
  • 7. Subject is receiving topical NSAID, other topical analgesics/counterirritants/ mineral oils/Ayurvedic oils, or other medication (such as corticosteroid w thin 3 weeks of visit I) which, in the opinion of the investigative personnel, will interfere with the study results,
  • 8. Subject on vasodilator drugs including anti-hypertensives, drugs for Peripheral vascular disease.
  • 9.Substance abuse: Recent history (within the last one year) of alcohol or other substance abuse.
  • 10.Personnel: An employee of the sponsor or the study site or members of their immediate family,

研究者

相似试验